These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7036475)

  • 1. Donor-reactive lymphocytes are opsonized in mice with passively enhanced skin allografts but not in tolerant mice.
    Hutchinson IV; Rayfield LS; Brent L
    Transplantation; 1982 Feb; 33(2):204-6. PubMed ID: 7036475
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of IgG and IgM alloantibodies in the enhancement of mouse skin allografts and the relation with their opsonizing capacity in vivo.
    Lems SP; Tamboer WP; Capel PJ; Koene RA
    J Immunol; 1981 Aug; 127(2):665-9. PubMed ID: 7019328
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of alloantibodies on corneal allograft survival.
    Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promotion of fetal liver cell engraftment in irradiated mice by activated T lymphocytes.
    Plotnicky H; Touraine JL
    Bone Marrow Transplant; 1993 Oct; 12(4):307-14. PubMed ID: 8275029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells.
    Emmanouilidis N; Guo Z; Dong Y; Newton-West M; Adams AB; Lee ED; Wang J; Pearson TC; Larsen CP; Newell KA
    Transplantation; 2006 Feb; 81(3):455-62. PubMed ID: 16477234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor microchimerism is not responsible for the maintenance of tolerance to donor alloantigens in recipients tolerant of cardiac allografts.
    Hamano K; Rawsthorne M; Bushell A; Morris PJ; Wood KJ
    Transplant Proc; 1995 Feb; 27(1):151-2. PubMed ID: 7878951
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of decomplementation with cobra venom factor on the passive immunological enhancement of mouse skin allografts.
    Hutchinson IV; Brent L
    Transplantation; 1982 Jul; 34(1):64-7. PubMed ID: 6750879
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
    Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro reactivity of lymphoid cells from tolerant mice.
    Beverley PC; Brent L; Brooks C; Medawar PB; Simpson E
    Transplant Proc; 1973 Mar; 5(1):679-84. PubMed ID: 4266673
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of removing lymphoid tissue on the persistence of tolerance of skin allografts in mice.
    Silvers WK
    J Immunol; 1974 Sep; 113(3):804-9. PubMed ID: 4607197
    [No Abstract]   [Full Text] [Related]  

  • 11. Lyt-2+ cells sensitized to graft alloantigens trigger the rejection of established cultured pancreatic islet allografts.
    Warren HS; Prowse SJ; Agostino M; Lafferty KJ
    Transplant Proc; 1984 Aug; 16(4):954-5. PubMed ID: 6431669
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation between lymphocyte-induced donor-specific tolerance and donor cell recirculation. Role of class I and class II major histocompatibility complex.
    Sheng-Tanner XF; Miller RG
    Transplantation; 1994 Apr; 57(7):1081-7. PubMed ID: 8165707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined anti-CD2 and anti-CD3 receptor monoclonal antibodies induce donor-specific tolerance in a cardiac transplant model.
    Chavin KD; Qin L; Lin J; Yagita H; Bromberg JS
    J Immunol; 1993 Dec; 151(12):7249-59. PubMed ID: 7903105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice.
    Krulová M; Zajícová A; Fric J; Holán V
    Transpl Int; 2002 Mar; 15(2-3):108-16. PubMed ID: 11935167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance to antigen-presenting cell-depleted islet allografts is CD4 T cell dependent.
    Coulombe M; Yang H; Wolf LA; Gill RG
    J Immunol; 1999 Mar; 162(5):2503-10. PubMed ID: 10072489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is antibody essential for enhancement of skin allograft survival following preinjection of donor lymphocyte antigens?
    Lee CK; Reif AE; Deterling RA
    Transplantation; 1972 Mar; 13(3):339-43. PubMed ID: 4553736
    [No Abstract]   [Full Text] [Related]  

  • 18. Conditions affecting enhanced corneal allograft survival by oral immunization.
    Ma D; Mellon J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1835-46. PubMed ID: 9727406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro expanded alloantigen-specific CD4+CD25+ regulatory T cell treatment for the induction of donor-specific transplantation tolerance.
    Jiang S; Golshayan D; Tsang J; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1879-82. PubMed ID: 17161340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimentally induced transplantation tolerance. I. Dissociation of effector lymphocytes specific for alloantigens by neonatal tolerance induction.
    Waterfield JD; Bick PH; Möller E; Möller G
    Scand J Immunol; 1981; 13(3):211-7. PubMed ID: 6453421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.